Baxter Plans New Kidney Care Business for Growth and Innovation

In 12-18 months, Baxter plans to spin off its Renal Care and Acute Therapies businesses into a separate publicly traded company.

Read the full article » | Posted 01-10-2023

Related Articles

• Nephrologist Dr. Roberto Collazo Shares New Treatments for Kidney Disease and ESKD Posted 12-11-2024
• Ellen Lukens from CMMI Presents on the Kidney Care Choices Model Posted 12-11-2024
• 2025 NKF Survey on Kidney Health Priorities Finds Home Dialysis is a Patient Priority Posted 12-11-2024
• FDA Correction on Baxter MiniCap Extended Life PD Transfer Set Posted 12-11-2024